Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.2%

8 terminated/withdrawn out of 155 trials

Success Rate

88.7%

+2.1% vs industry average

Late-Stage Pipeline

5%

8 trials in Phase 3/4

Results Transparency

10%

6 of 63 completed trials have results

Key Signals

14 recruiting6 with results4 withdrawn

Enrollment Performance

Analytics

N/A
49(59.0%)
Phase 1
20(24.1%)
Phase 2
6(7.2%)
Phase 4
4(4.8%)
Phase 3
4(4.8%)
83Total
N/A(49)
Phase 1(20)
Phase 2(6)
Phase 4(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (155)

Showing 20 of 155 trials
NCT07771478Not Yet Recruiting

Neonatal Enhanced Recovery After Surgery (ERAS) Outcomes Study

Role: collaborator

NCT05895032Not ApplicableCompleted

Trial of an Exercise Intervention for Children With Haemophilia

Role: collaborator

NCT06661278Completed

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

Role: collaborator

NCT07418723Not ApplicableCompleted

Personalised Process-based Psychological Interventions for Paediatric Headaches

Role: collaborator

NCT07771179Not Yet Recruiting

Children's Intensive Care Outcomes and Health Inequities: A Mixed Methods Study of Social Determinants in Paediatric Intensive Care in England

Role: collaborator

NCT06976086Not ApplicableActive Not Recruiting

Pediatric Expansion Study of the Sentio System

Role: collaborator

NCT02300766Recruiting

Cerebellar Mutism Syndrome Study

Role: collaborator

NCT06974162Recruiting

Metagenomics for Ocular Inflammation

Role: collaborator

NCT07699107Phase 4Not Yet Recruiting

Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT05665166Phase 1Active Not Recruiting

Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II

Role: collaborator

NCT04337450Phase 2Active Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Role: collaborator

NCT07412886Not ApplicableNot Yet Recruiting

Advanced MRI in IVH

Role: lead

NCT06453759Not ApplicableRecruiting

Thalamic Recordings in Children Undergoing SEEG

Role: lead

NCT04101903Not ApplicableActive Not Recruiting

Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice

Role: lead

NCT05942599Phase 1Active Not Recruiting

Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation

Role: lead

NCT04049084Enrolling By Invitation

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

Role: collaborator

NCT06924086Not ApplicableNot Yet Recruiting

The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial

Role: collaborator

NCT03706482Phase 1Active Not Recruiting

Boost Brittle Bones Before Birth

Role: collaborator

NCT05437393Not ApplicableCompleted

Children's Adaptive Deep Brain Stimulation for Epilepsy Trial (CADET): Pilot

Role: collaborator